HER-2/neu Amplification Testing in Breast Cancer by Multiplex Ligation-Dependent Probe Amplification in Comparison with Immunohistochemistry and In Situ Hybridization

Background: Assessment of HER-2/neu status in invasive breast cancer is crucial to establish eligibility for trastuzumab and taxane based chemotherapy. Next to immunohistochemistry (IHC) to evaluate protein overexpression, a second line gene amplification test is required for cases with equivocal pr...

Full description

Saved in:
Bibliographic Details
Main Authors: Cathy B. Moelans, Roel A. de Weger, Marja T.M. van Blokland, Chantal Ezendam, Sabrina Elshof, Marcel G. J. Tilanus, Paul J. van Diest
Format: Article
Language:English
Published: Wiley 2009-01-01
Series:Cellular Oncology
Online Access:http://dx.doi.org/10.3233/CLO-2009-0461
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832566627015589888
author Cathy B. Moelans
Roel A. de Weger
Marja T.M. van Blokland
Chantal Ezendam
Sabrina Elshof
Marcel G. J. Tilanus
Paul J. van Diest
author_facet Cathy B. Moelans
Roel A. de Weger
Marja T.M. van Blokland
Chantal Ezendam
Sabrina Elshof
Marcel G. J. Tilanus
Paul J. van Diest
author_sort Cathy B. Moelans
collection DOAJ
description Background: Assessment of HER-2/neu status in invasive breast cancer is crucial to establish eligibility for trastuzumab and taxane based chemotherapy. Next to immunohistochemistry (IHC) to evaluate protein overexpression, a second line gene amplification test is required for cases with equivocal protein expression. This study aimed to validate a new PCR based test, called Multiplex Ligation-dependent Probe Amplification (MLPA), as a simple and quick method to assess HER-2/neu gene amplification status in invasive breast cancer.
format Article
id doaj-art-94711039197844a190f01ba1b7778195
institution Kabale University
issn 1570-5870
1875-8606
language English
publishDate 2009-01-01
publisher Wiley
record_format Article
series Cellular Oncology
spelling doaj-art-94711039197844a190f01ba1b77781952025-02-03T01:03:38ZengWileyCellular Oncology1570-58701875-86062009-01-0131111010.3233/CLO-2009-0461HER-2/neu Amplification Testing in Breast Cancer by Multiplex Ligation-Dependent Probe Amplification in Comparison with Immunohistochemistry and In Situ HybridizationCathy B. Moelans0Roel A. de Weger1Marja T.M. van Blokland2Chantal Ezendam3Sabrina Elshof4Marcel G. J. Tilanus5Paul J. van Diest6Department of Pathology, University Medical Centre Utrecht, Utrecht, The NetherlandsDepartment of Pathology, University Medical Centre Utrecht, Utrecht, The NetherlandsDepartment of Pathology, University Medical Centre Utrecht, Utrecht, The NetherlandsDepartment of Pathology, University Medical Centre Utrecht, Utrecht, The NetherlandsDepartment of Pathology, University Medical Centre Utrecht, Utrecht, The NetherlandsDepartment of Pathology, University Medical Centre Utrecht, Utrecht, The NetherlandsDepartment of Pathology, University Medical Centre Utrecht, Utrecht, The NetherlandsBackground: Assessment of HER-2/neu status in invasive breast cancer is crucial to establish eligibility for trastuzumab and taxane based chemotherapy. Next to immunohistochemistry (IHC) to evaluate protein overexpression, a second line gene amplification test is required for cases with equivocal protein expression. This study aimed to validate a new PCR based test, called Multiplex Ligation-dependent Probe Amplification (MLPA), as a simple and quick method to assess HER-2/neu gene amplification status in invasive breast cancer.http://dx.doi.org/10.3233/CLO-2009-0461
spellingShingle Cathy B. Moelans
Roel A. de Weger
Marja T.M. van Blokland
Chantal Ezendam
Sabrina Elshof
Marcel G. J. Tilanus
Paul J. van Diest
HER-2/neu Amplification Testing in Breast Cancer by Multiplex Ligation-Dependent Probe Amplification in Comparison with Immunohistochemistry and In Situ Hybridization
Cellular Oncology
title HER-2/neu Amplification Testing in Breast Cancer by Multiplex Ligation-Dependent Probe Amplification in Comparison with Immunohistochemistry and In Situ Hybridization
title_full HER-2/neu Amplification Testing in Breast Cancer by Multiplex Ligation-Dependent Probe Amplification in Comparison with Immunohistochemistry and In Situ Hybridization
title_fullStr HER-2/neu Amplification Testing in Breast Cancer by Multiplex Ligation-Dependent Probe Amplification in Comparison with Immunohistochemistry and In Situ Hybridization
title_full_unstemmed HER-2/neu Amplification Testing in Breast Cancer by Multiplex Ligation-Dependent Probe Amplification in Comparison with Immunohistochemistry and In Situ Hybridization
title_short HER-2/neu Amplification Testing in Breast Cancer by Multiplex Ligation-Dependent Probe Amplification in Comparison with Immunohistochemistry and In Situ Hybridization
title_sort her 2 neu amplification testing in breast cancer by multiplex ligation dependent probe amplification in comparison with immunohistochemistry and in situ hybridization
url http://dx.doi.org/10.3233/CLO-2009-0461
work_keys_str_mv AT cathybmoelans her2neuamplificationtestinginbreastcancerbymultiplexligationdependentprobeamplificationincomparisonwithimmunohistochemistryandinsituhybridization
AT roeladeweger her2neuamplificationtestinginbreastcancerbymultiplexligationdependentprobeamplificationincomparisonwithimmunohistochemistryandinsituhybridization
AT marjatmvanblokland her2neuamplificationtestinginbreastcancerbymultiplexligationdependentprobeamplificationincomparisonwithimmunohistochemistryandinsituhybridization
AT chantalezendam her2neuamplificationtestinginbreastcancerbymultiplexligationdependentprobeamplificationincomparisonwithimmunohistochemistryandinsituhybridization
AT sabrinaelshof her2neuamplificationtestinginbreastcancerbymultiplexligationdependentprobeamplificationincomparisonwithimmunohistochemistryandinsituhybridization
AT marcelgjtilanus her2neuamplificationtestinginbreastcancerbymultiplexligationdependentprobeamplificationincomparisonwithimmunohistochemistryandinsituhybridization
AT pauljvandiest her2neuamplificationtestinginbreastcancerbymultiplexligationdependentprobeamplificationincomparisonwithimmunohistochemistryandinsituhybridization